WO2001042464A3 - Facteur 2 de regulation preoptique humain et ses utilisations - Google Patents

Facteur 2 de regulation preoptique humain et ses utilisations Download PDF

Info

Publication number
WO2001042464A3
WO2001042464A3 PCT/US2000/030169 US0030169W WO0142464A3 WO 2001042464 A3 WO2001042464 A3 WO 2001042464A3 US 0030169 W US0030169 W US 0030169W WO 0142464 A3 WO0142464 A3 WO 0142464A3
Authority
WO
WIPO (PCT)
Prior art keywords
human
regulatory factor
hporf
preoptic
polypeptides
Prior art date
Application number
PCT/US2000/030169
Other languages
English (en)
Other versions
WO2001042464A2 (fr
Inventor
Xuan Mei Li
Paul Robert Junior Rosteck
Eric Wen Su
He Wang
Jian-Jun Wei
Original Assignee
Lilly Co Eli
Xuan Mei Li
Paul Robert Junior Rosteck
Eric Wen Su
He Wang
Wei Jian Jun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Xuan Mei Li, Paul Robert Junior Rosteck, Eric Wen Su, He Wang, Wei Jian Jun filed Critical Lilly Co Eli
Priority to AU17558/01A priority Critical patent/AU1755801A/en
Publication of WO2001042464A2 publication Critical patent/WO2001042464A2/fr
Publication of WO2001042464A3 publication Critical patent/WO2001042464A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouveaux polypeptides du facteur 2 de régulation préoptique humain (hPROF-2), comprenant des acides nucléiques isolés qui codent des polypeptides du hPROF-2, des vecteurs, des cellules hôtes, des produits transgéniques, des produits chimères, des anticorps spécifiques au hPROF-2, ainsi que leur procédés de production et d'utilisation.
PCT/US2000/030169 1999-12-08 2000-11-30 Facteur 2 de regulation preoptique humain et ses utilisations WO2001042464A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17558/01A AU1755801A (en) 1999-12-08 2000-11-30 Human preoptic regulatory factor-2 and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16968699P 1999-12-08 1999-12-08
US60/169,686 1999-12-08

Publications (2)

Publication Number Publication Date
WO2001042464A2 WO2001042464A2 (fr) 2001-06-14
WO2001042464A3 true WO2001042464A3 (fr) 2002-02-14

Family

ID=22616750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030169 WO2001042464A2 (fr) 1999-12-08 2000-11-30 Facteur 2 de regulation preoptique humain et ses utilisations

Country Status (2)

Country Link
AU (1) AU1755801A (fr)
WO (1) WO2001042464A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115300626B (zh) * 2021-11-03 2024-05-10 上海市奉贤区中心医院 一种用于治疗神经损伤疾病的基因药物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025423A1 (fr) * 1995-02-17 1996-08-22 Mount Sinai School Of Medicine Of The City University Of New York Inhibition et modulation de l'activite du recepteur de la gonadoliberine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025423A1 (fr) * 1995-02-17 1996-08-22 Mount Sinai School Of Medicine Of The City University Of New York Inhibition et modulation de l'activite du recepteur de la gonadoliberine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_EST EMBL Heidelberg, Germany; 12 March 1999 (1999-03-12), OTTENWAELDER B ET AL.: "Homo sapiens mRNA; EST DKFZp434A2418_r1", XP002172811 *
DATABASE EM_EST EMBL Heidelberg, Germany; 13 September 1999 (1999-09-13), NCI/NINDS-CGAP: "Homo sapiens cDNA clone IMAGE: 2500616", XP002172812 *
DATABASE EM_HTG EMBL Heidelberg, Germany; 7 February 2000 (2000-02-07), MUZNY D M ET AL.: "Homo sapiens clone RP11349C2", XP002172813 *
NOWAK F V: "CLONING OF TWO HYPOTHALAMIC COMPLEMENTARY DNA ENCODING TISSUE-SPECIFIC TRANSCRIPTS IN THE PREOPTIC AREA AND TESTIS", MOLECULAR ENDOCRINOLOGY, vol. 4, no. 8, 1990, pages 1205 - 1210, XP001010481, ISSN: 0888-8809 *

Also Published As

Publication number Publication date
AU1755801A (en) 2001-06-18
WO2001042464A2 (fr) 2001-06-14

Similar Documents

Publication Publication Date Title
WO2004003147A3 (fr) Polypeptides cngh0004, anticorps, compositions, procedes et utilisations
WO2002012501A3 (fr) Anticorps anti-integrines doubles, compositions, procedes et utilisations associes
WO2002012500A3 (fr) Anticorps, compositions, procedes anti-il-12 et leur utilisation
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2005005604A3 (fr) Proteines derivees de l'immunoglobuline anti-cible et genetiquement modifiees, compositions, procedes et utilisations
WO2001049728A3 (fr) Proteines humaines a domaines hydrophobes et adn codant ces proteines
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
TW200716745A (en) Anti-TNF antibodies, compositions, methods and uses
WO2001029222A3 (fr) Polypeptides ayant une activite phospholipase b et acides nucleiques codant ces derniers
WO2002062999A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2003038041A3 (fr) Mut-il-4: proteines, anticorps, compositions, procedes et utilisations
WO2003047510A3 (fr) Anticorps anti-tnf, compositions, procedes et utilisations
WO2001012660A3 (fr) Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
WO2002036627A3 (fr) Interferons, utilisations et compositions associees
WO2003057821A3 (fr) Proteines et anticorps mut-il-18 or mut-il-18r, compositions, procedes et utilisations
WO2001002563A3 (fr) Proteines humaines ayant des domaines hydrophobes et adn codant pour ces proteines
WO2000059942A3 (fr) COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS
WO2003102017A3 (fr) Anticorps diriges contre la fusion de la proteine de type reg, compositions, procedes et utilisations
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
WO2001042464A3 (fr) Facteur 2 de regulation preoptique humain et ses utilisations
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2000041509A3 (fr) Polypeptides possedant une activite de phosphatase acide et acides nucleiques codant pour ceux-ci
WO2001083552A3 (fr) Acides nucleiques et polypeptides sez6 humains
WO2003063767A3 (fr) Proteines du vrs, anticorps, compositions, procedes et utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10129851

Country of ref document: US

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP